The Single Drug That Reduces COVID-19 Death Rate

Buteyko Breathing Meets Modern Science

A group of scientists assembled under the leadership of the University of Oxford recently discovered that one low-cost, low-dose drug works wonders in battling COVID-19. For many doctors and scientists, discovering a common to drug to be so effective is surprising — but the results are predictable for adherents of the Buteyko Breathing Normalization method.

The Oxford group recruited nearly 12,000 COVID-19 patients in UK hospitals, then randomly assigned them to several experimental treatment groups.

The goal of project RECOVERY was to compare several likely drug therapies:

· Lopinavir-Ritonavir (an HIV drug)

· Low-dose Dexamethasone (a steroid, which is typically used to reduce inflammation)

· Azithromycin (a common antibiotic)

· Hydroxychloroquine (used to treat Lupus)

· Convalescent plasma (collected from donors who have recovered from COVID-19, with contains antibodies against the SARS-CoV-2 virus).

· Tocilizumab (an injected anti-inflammatory)

The results were eye-opening. Low-dose Dexamethasone produced impressive outcomes for two patient subgroups: those on…